Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticlePsoriatic Arthritis

Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs

Neil McHugh, Áine Maguire, Ian Handel, William Tillett, James Morris, Neil Hawkins, Charlotte Cavill, Eleanor Korendowych and Farhan Mughal
The Journal of Rheumatology May 2020, 47 (5) 701-707; DOI: https://doi.org/10.3899/jrheum.190083
Neil McHugh
From the Royal National Hospital for Rheumatic Disease, NHS Foundation Trust, Bath; University of Cambridge, Cambridge; Royal (Dick) School of Veterinary Studies, University of Edinburgh, Edinburgh; University of Bath, Bath; Cogentia Healthcare Consulting Ltd., Cambridge; University of Glasgow, Glasgow; and Celgene Ltd., Uxbridge, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Neil McHugh
  • For correspondence: n.j.mchugh{at}bath.ac.uk
Áine Maguire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Áine Maguire
Ian Handel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ian Handel
William Tillett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for William Tillett
James Morris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Neil Hawkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charlotte Cavill
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eleanor Korendowych
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Farhan Mughal
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Figures

  • Tables
  • Relationship between HAQ-DI and total healthcare costs: a regression model scatter plot. HAQ-DI: Health Assessment Questionnaire–Disability Index.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Relationship between HAQ-DI and total healthcare costs: a regression model scatter plot. HAQ-DI: Health Assessment Questionnaire–Disability Index.

  • HAQ-DI coefficient for resource use categories. Coefficient for medications (£58.07) and CI (−788 to 966) not shown. HAQ-DI: Health Assessment Questionnaire-Disability Index.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    HAQ-DI coefficient for resource use categories. Coefficient for medications (£58.07) and CI (−788 to 966) not shown. HAQ-DI: Health Assessment Questionnaire-Disability Index.

Tables

  • Figures
    • View popup
    Table 1.

    Patient characteristics.

    CharacteristicsStudy Population
    Patients, N101
    Age, yrs, mean (SD)57.83 (10.66)
    Sex, female/male, n (%)58 (57)/43 (43)
    HAQ-DI score, mean (SD)0.84 (0.75)
    Disease duration, yrs, mean (SD)18.23 (11.26)
    • HAQ-DI: Health Assessment Questionnaire-Disability Index.

    • View popup
    Table 2.

    Healthcare costs per patient* by resource use category (£/unit, 2016 prices).

    Resource Use CategoryMean (SD)Median (IQR)Range
    Tests£146 (£117)£126 (£137)£0–£690
    A&E visit£14 (£35)£0 (£0)£0–£154
    Primary care consultation£247 (£198)£195 (£256)£0–£1101
    Secondary care consultation£678 (£445)£594 (£445)£0–£2635
    Admitted care£502 (£1415)£0 (£0)£0–£6660
    Medication costs£2284 (£3493)£390 (£3560)£0–£16,326
    Total costs£3870 (£3986)£2123 (£4952)£175–£17,771
    Total costs (excluding medication costs)£1586 (£1639)£1111 (£1213)£174–£8854
    • ↵* Based on study population of 101 patients, the n values used to calculate values shown may vary slightly across cost categories because of missing data. A&E: accident and emergency department; IQR: interquartile range.

    • View popup
    Table 3.

    Output results of the linear regression modeling.

    Covariatesβ (SE)p95% CI for β
    HAQ-DI total cost (excluding medications)£547 (£224)0.006197–1120
    Intercept total cost (excluding medications)£1128 (£200)< 0.001792–1596
    No. observations101
    Log likelihood−887.1
    Adjusted R20.053
    • HAQ-DI: Health Assessment Questionnaire-Disability Index; SE: standard error.

    • View popup
    Table 4.

    Results of the regression modeling: estimated HAQ-DI coefficient.

    AnalysesEstimated HAQ-DI Coefficient from Regression of Costs in HAQ-DI (£/unit)
    Estimate (SE)*95% CIp
    Primary analysis
      Tests£21.45 (£14)−7 to 480.121
      A&E visit£15.67 (£6)7 to 290.001
      Primary care consultation£69.98 (£25)21 to 1170.007
      Secondary care consultation£278.14 (£50)185 to 381< 0.001
      Medications£58.07 (£447)−788 to 9660.903
      Admitted care£162.25 (£200)−131 to 7160.437
      Total costs (w/o meds)£547.49 (£224)197 to 11200.006
    Sensitivity analyses for total costs (excluding medication cost)
      Disease duration, yrs
        0 to < 5 (n = 6)£−76.97 (£499)−1335 to 7790.852
        5 to < 10 (n = 12)£390.47 (£834)−275 to 41180.656
        ≥ 10 (n = 63)£626.50 (£264)212 to 12980.008
      HAQ-DI
        0 to < 1 (n = 58)£981.68 (£572)−15 to 22630.066
        1 to < 2 (n = 33)£116.88 (£904)−2066 to 16150.849
        ≥ 2 (n = 10)£3340.13 (£3693)883 to 15,3030.051
      Sex
        Female (n = 58)£480.3 (£377)−123 to 14070.208
        Male (n = 43)£520.92 (£264)148 to 12730.014
    • ↵* Bootstrapped SE. A&E: accident and emergency department; HAQ-DI: Health Assessment Questionnaire–Disability Index; SE: standard error.

  • Primary AnalysisEstimated HAQ-DI Coefficient from Regression of Costs in HAQ-DI (£/unit)
    Estimate (SE)*95% CIp
    Tests£18.19 (£15)−12 to 460.209
    A&E visit£17.27 (£6)7 to 310.001
    Primary care consultation£67.26 (£27)14 to 1190.015
    Secondary care consultation£264.55 (£51)170 to 369< 0.001
    Medications£−57.78 (£439)−873 to 8570.884
    Admitted care£18.86 (£48)−101 to 970.654
    Total costs (without medication)£386.13 (£93)202 to 566< 0.001
    • A&E: accident and emergency department; HAQ-DI: Health Assessment Questionnaire–Disability Index; SE: standard error.

  • VariablesEstimated HAQ-DI Coefficient from Regression of log10 (costs + 1) in HAQ-DI (£/unit)
    Estimate (SE)*Estimate ^10 (CI)p
    Tests0.129 (0.066)1.344 (0.966–1.814)0.053
    A&E visit0.300 (0.089)1.997 (1.331–2.995)0.001
    Primary care consultation0.130 (0.070)1.350 (0.981–1.856)0.065
    Secondary care consultation0.147 (0.050)1.403 (1.116–1.764)0.004
    Medications0.073 (0.128)1.182 (0.660–2.118)0.571
    Admitted care0.275 (0.173)1.882 (0.854–4.149)0.116
    Total costs (without medication)0.172 (0.042)1.485 (1.223–1.803)< 0.001
    • A&E: accident and emergency department; HAQ-DI: Health Assessment Questionnaire–Disability Index; SE: standard error.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 47, Issue 5
1 May 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs
Neil McHugh, Áine Maguire, Ian Handel, William Tillett, James Morris, Neil Hawkins, Charlotte Cavill, Eleanor Korendowych, Farhan Mughal
The Journal of Rheumatology May 2020, 47 (5) 701-707; DOI: 10.3899/jrheum.190083

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Evaluation of the Economic Burden of Psoriatic Arthritis and the Relationship Between Functional Status and Healthcare Costs
Neil McHugh, Áine Maguire, Ian Handel, William Tillett, James Morris, Neil Hawkins, Charlotte Cavill, Eleanor Korendowych, Farhan Mughal
The Journal of Rheumatology May 2020, 47 (5) 701-707; DOI: 10.3899/jrheum.190083
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • APPENDIX 1. Results of the regression model excluding 6 patients whose total costs without medications exceeded £5000: estimated HAQ-DI coefficient.
    • APPENDIX 2. Results of the regression modeling: estimated HAQ-DI coefficient from regression of log10 (costs + 1).
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

PSORIATIC ARTHRITIS
ECONOMIC BURDEN OF DISEASE
HEALTHCARE COSTS
REGRESSION ANALYSIS

Related Articles

Cited By...

More in this TOC Section

  • Clinical and Histopathologic Characteristics and Outcomes of Patients With Psoriatic Arthritis Undergoing Arthroplasty
  • Overall and Sex-Specific Predictors of Secukinumab Effectiveness in European Patients With Psoriatic Arthritis: Results From the EuroSpA Collaboration
  • Further Validation of a Questionnaire to Assess Flare in Psoriatic Arthritis: Determination of Cutoff and Longitudinal Change
Show more Psoriatic Arthritis

Similar Articles

Keywords

  • psoriatic arthritis
  • ECONOMIC BURDEN OF DISEASE
  • healthcare costs
  • REGRESSION ANALYSIS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire